ARWRSTOCK_USDT
トークン名 ARWRSTOCK
循環率 0.00%
取引ルール (ARWRUSDT Perpetual)
レバレッジ 1 ~ 20
最低注文数量 0.5946 USDT
一回の成行注文で出せる最大数量 1,010.82 USDT
一回の指値注文で出せる最大数量 1,010.82 USDT
最低価格変更 0.01
指値注文の上限価格/下限価格比率 20% / 20%
オープン注文の最大数量 50
価格保護 10%
サイズ 1 枚 = 0.01 ARWR
強制決済手数料 0.02%
先物取引ルールをすべて表示テクニカル分析は、さまざまな指標やデータに基づき、売買のタイミングを見極めるために行われます。
数値
| 名称 | 価値 | 操作 |
|---|
| KDJ (9,3,3)_K | 24.154 | 購入 |
| KDJ (9,3,3)_D | 16.479 | 購入 |
| KDJ (9,3,3)_J | 39.5041 | 購入 |
| RSI (14) | 40.5235 | 購入 |
| StochRSI (%K) | 56.9225 | 売却 |
| StochRSI (%D) | 34.9732 | 購入 |
多角的
| 名称 | 操作 |
|---|
| KDJ (9,3,3)_K&D | 購入 |
| KDJ (9,3,3) ゴールデンクロス/デスクロス | 購入 |
| MACD (12,26,9) ゴールデンクロス/デスクロス | 購入 |
| DEAが0軸を越える | 売却 |
| BOLL (20,2) 過剰買い/過剰売り | 中立 |
| BOLL (20,2) ミドルバンドゴールデンクロス/デスクロス | 売却 |
概要: 売却 9 · 中立 1 · 購入 16 — 購入
概要
Arrowhead Pharmaceuticals, Inc. has developed a drug that treats intractable diseases by inhibiting the genes that cause them, thus silencing the genes. Arrowhead therapy utilizes a wide range of RNA chemicals and efficient delivery methods to trigger RNA interference mechanisms, inducing rapid, deep, and durable knockout of target genes. RNA interference (RNAi) is a mechanism present in living cells that inhibits the expression of specific genes, thereby affecting the production of specific proteins. RNAi is considered one of the most important recent discoveries in life sciences, with the potential to revolutionize medicine. The discoverers of RNAi were awarded the Nobel Prize in 2006 for their work. Arrowhead Pharmaceuticals, Inc.'s RNAi-based therapy utilizes this natural pathway of gene silencing.
Disclaimer: Data is collected from third-party platforms, provided for reference only, and does not constitute any form of investment advice or guarantee.